Evidence map›Paper›PMID 42509255›Full record

ArticleLeukemia2026

Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia.

Yasuo Kubota, Yasuhiro Okamoto, Toshihiko Imamura, Akiko Kada, Akiko M Saito, Yuka Iijima-Yamashita, Masashi Sanada, Tomohiko Taki, Katsuyoshi Koh, Motohiro Kato

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yasuo KubotaDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7909-5422
Yasuhiro OkamotoDepartment of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Toshihiko ImamuraDepartment of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Akiko KadaClinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.ORCID http://orcid.org/0000-0001-6350-5389
Akiko M SaitoClinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
Yuka Iijima-YamashitaClinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
Masashi SanadaClinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
Tomohiko TakiDepartment of Medical Technology, Kyorin University Faculty of Health Sciences, Mitaka, Japan.ORCID http://orcid.org/0000-0002-0054-410X
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Motohiro KatoDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. katom-tky@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0001-5145-1774

Funding

Japan Agency for Medical Research and Development (AMED) JP23ck0106876Japan Agency for Medical Research and Development (AMED) JP24ck0106955Japan Agency for Medical Research and Development (AMED) JP25ck0106041
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42509255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.